Research reports the results of a randomized, placebo-controlled trial that investigated the effects of combining fluvoxamine and inhaled budesonide for preventing disease progression in high-risk outpatients with COVID-19. The study found that the combination treatment reduced the incidence of severe disease requiring advanced care.
Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients
- Thread starter Educator
- Start date